Full-Time

Senior Manager

Health, Safety & Environment Management

Updated on 7/21/2026

Deadline 8/31/26
Alcon

Alcon

10,001+ employees

Eye care products and vision solutions

No salary listed

Fort Worth, TX, USA

In Person

Category
Biology & Biotech (1)

Get referred to Alcon

Find people who can refer or advise you

Requirements
  • Bachelor’s Degree or Equivalent years of directly related experience (or high school+15 yrs; Assoc.+11 yrs; M.S.+4 yrs; PhD+3 yrs)
  • The ability to fluently read, write, understand, and communicate in English
  • 7 Years of Relevant Experience
Responsibilities
  • Lead the global Environmental Product Compliance strategy across product design, packaging, and end‑of‑life waste management
  • Develop and implement globally aligned environmental product compliance programs, standards, targets, and performance criteria
  • Serve as Alcon’s representative with external industry and regulatory organizations (e.g., Medical Device Summit, EDMA)
  • Monitor, interpret, and assess global environmental product regulations and drive timely compliance plans
  • Identify chemical regulatory risks and lead mitigation strategies through Alcon’s Environmental Product Compliance process
  • Own and drive the Environmental Product Compliance Process, ensuring adherence to internal procedures and external regulations (e.g., REACH, RoHS, MDR, CE)
  • Manage the collection, validation, and maintenance of product‑related environmental data (regulatory declarations, chemical content, packaging materials, sizes, etc.) from internal teams and suppliers
  • Partner with R&D to conduct environmental compliance assessments during product development to enable global market access (RoHS, REACH, WEEE, Packaging Waste, Prop 65, etc.)
  • Lead the Product Life Cycle Assessment (LCA) program to measure sustainability impact and performance metrics
  • Manage responses to internal and external environmental compliance inquiries, including tender and customer requests
  • Oversee generation and maintenance of Safety Data Sheets (SDS) for new and existing products
  • Manage Extended Producer Responsibility (EPR) programs, including external agreements, data collection, regulatory reporting, and fee payments

Alcon provides eye care products and vision solutions to improve how people see. It develops and manufactures devices and consumables for eye health, including cataract surgery equipment and intraocular lenses, retinal health therapies, and contact lenses, distributed through eye care professionals, hospitals, and consumers. The products work by supporting eye surgery, protecting and restoring vision, or correcting vision with lens-based options, backed by research and development and a global distribution network. Alcon differentiates itself with a broad, end-to-end portfolio across the eye care continuum, a strong emphasis on research and development, strategic partnerships with healthcare providers, and a commitment to diversity and inclusion. Its goal is to enhance vision and quality of life by delivering reliable, high-quality eye care solutions and advancing the science of eye health.

Company Size

10,001+

Company Stage

IPO

Headquarters

Geneva, Switzerland

Founded

1945

Get referred to Alcon

Find people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 2026 RxSight deal adds $30–$40M to 2026 revenue via adjustable PCIOLs[1][2].
  • June 2026 UNITY CS launch in Canada cuts eye energy by 40% and speeds removal 2x[2].
  • June 2026 toric lens expansion covers 99% of astigmatic eyes, boosting first-fit success[2].

What critics are saying

  • RxSight's 10% Q2 2026 unit drop threatens $30–$40M adjustable PCIOL revenue in 12–18 months[2].
  • UST tariffs will cost $50–$100M in 2026, compressing operating margin by 70–170 bps[2].
  • EU MDR and FDA delays will stall UNITY CS commercialization, adding $20–$40M compliance costs in 12–18 months[2].

What makes Alcon unique

  • Alcon leads eye care with 75+ years heritage and 260 million patients across 140 countries[1].
  • Alcon uniquely combines PCIOL optics with RxSight's light-adjustable tech for tunable post-surgery outcomes[1][2].
  • Alcon offers the broadest eye care portfolio spanning surgical, vision care, and dry eye categories[1].

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical, dental, & vision coverage

HSA Medical Plan

PTO

Paid Parental leave

401k

Retirement Plan Company Contribution

Low payroll deductions

Tuition Reimbursement Program

Annual Bonus

Free Family Contact Lens Program

12 Company Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

11%

1 year growth

11%

2 year growth

11%
0xBasinas
Jul 10th, 2026
Three major breaches in two weeks: what security teams can learn from July 2026.

Three major breaches in two weeks: what security teams can learn from July 2026. 10 July 2026 July 2026 is shaping up to be a rough month for data security. In the past two weeks, 0xbasinas has seen alleged breaches at Nike and Alcon, a confirmed zero-day exploitation at Japanese telecom KDDI affecting 12 million people, and an intrusion at Accenture where a hacker claims to have stolen 35GB of source code and cloud credentials. These incidents are not isolated. They share patterns that security teams should pay attention to. I will walk through each incident, look at what actually happened versus what is claimed, and pull out the practical takeaways. Nike and Alcon: unverified claims with worrying details. On July 6, a threat actor using the alias Nocturne posted on a dark web forum claiming to have stolen customer data from Nike and internal records from Alcon, an ophthalmology device and pharmaceutical company. According to DarkWebInformer, the Nike data is described as "eight figures" of records, all from 2026 customer registrations and orders. The uncompressed archive is over 40GB and contains only CSV files. For Alcon, the claimed breach is more varied. The actor says they stole user sign-up information for Alcon's MARLO platform, including full names, addresses, phone numbers. They also claim to have taken Salesforce supplier data, internal MARLO conversation logs, order numbers, and source code. The sample shared includes fields like SAP IDs, credit limits, and geographic classification data. Neither Nike nor Alcon has confirmed any breach. The actor claims Alcon initially negotiated and received data samples, then backed out, prompting the leak. The post includes a direct message calling out Alcon for not disclosing the breach to customers. Some context: this is not Nike's first alleged breach in 2026. In January, the WorldLeaks ransomware gang claimed to have stolen 1.4TB of internal data, including 190,000 files about design and manufacturing. That incident reportedly involved insider access, not customer records. Nike never confirmed that one either. What this means for defenders. Unverified claims are frustrating. You cannot act on a dark web post alone, but you also cannot ignore the possibility. The safety move is to monitor for credential stuffing attempts on your own systems. If you are a Nike customer, change your password anyway. If you work with Alcon's MARLO platform or Salesforce integration, treat the claims as credible enough to review access logs for anomalous activity. The 40GB figure and sample screenshots are not proof, but they are enough to justify proactive investigation. KDDI: a zero-day in custom email infrastructure. On June 17, Japanese telecommunications giant KDDI detected unauthorized access to a system that is part of the email infrastructure used by five ISPs: STNet, JCOM, Chubu Telecommunications, NIFTY, and BIGLOBE. KDDI confirmed this week that 12.2 million email addresses and 7.6 million passwords were compromised. The attack exploited a zero-day vulnerability in software that KDDI built as part of that email system. The company says the exploitation may have been ongoing since May. They evicted the attackers immediately after discovery and found no evidence of additional suspicious activity. They are now working with the software vendor on a patch. Mandatory password resets are being rolled out. KDDI also said that mobile and fixed-line internet services were not affected, because those operate on separate infrastructure. What this means for defenders. A zero-day in custom software is every security team's nightmare. You cannot rely on off-the-shelf patches if the vulnerability is in your own code or a bespoke integration. The attackers got in through the email system, not the core network, which suggests they were after credentials. Password resets are the obvious fix, but the more important lesson is about segmentation. KDDI's mobile and fixed-line services remained unaffected because they were on different infrastructure. That is the kind of architectural decision that pays off when an incident happens. The incident also reinforces a basic truth: if you run an email service that stores plaintext or weakly hashed passwords, you are a target. KDDI says passwords were compromised, but they did not specify whether they were hashed. Given the scale, every affected user should assume their password is in the hands of attackers. Accenture: confirmed intrusion, claimed exfiltration of secrets. On July 6, a hacker using the handle "888" posted on a cybercrime forum claiming to have 35GB of data stolen from Accenture. The list includes source code, RSA keys, SSH keys, Azure Personal Access Tokens, Azure Storage access keys, configuration files, and other data. The hacker is asking for payment in Monero. Accenture confirmed the intrusion and said they identified the source and remediated it. They said the incident had no impact on their financial position or operations. They did not confirm or deny the specifics of the data theft. This is not the first time this hacker has sold Accenture data. In 2024, "888" claimed to have stolen PII of 30,000 employees. Accenture said at the time that the real number was closer to three employees. It is possible this latest claim is similarly exaggerated. But even if the actual data volume is smaller, the nature of the claimed data is concerning. Source code is one thing; RSA keys, SSH keys, and Azure PATs are another. Those credentials, if real, could be used to access Accenture's cloud environments and potentially the environments of their clients. Accenture works with many Fortune 500 companies. A breach of their internal cloud management keys would be worse than a breach of customer data. What this means for defenders. If you run a consultancy or a managed service provider, your secrets are your crown jewels. Attackers know that stealing a cloud token from an MSP is more valuable than stealing a thousand credit card numbers. The practical takeaway is to rotate all secrets regularly, enforce minimal permissions for service accounts, and monitor for token exfiltration. The fact that Accenture says they evicted the attacker and saw no further activity is good, but it does not mean the data is gone. The attacker likely already exfiltrated everything they could before the intrusion was detected. Common threads and what to do about them. All three incidents share a few things. First, they involve third-party or custom software that attackers exploited. KDDI's zero-day was in their own email system. Alcon's MARLO platform was allegedly compromised. Accenture's intrusion, whatever the vector, gave the attacker access to cloud credentials tied to client infrastructure. Second, in two of three cases the companies took days or weeks to confirm the breach. KDDI detected on June 17 and confirmed in early July. Accenture confirmed within days of the post, but the data may have been stolen earlier. Nike and Alcon have not confirmed at all. Third, the attackers went after login credentials and secrets. At KDDI, email passwords. At Accenture, cloud tokens. At Alcon, user registration data. Credential theft is the common denominator. What security teams should do right now. Rotate any secrets that may be exposed through third-party integrations. If you use Alcon's MARLO or Salesforce connections, force password resets for users of those platforms. If you are an Accenture client, ask for an audit of any shared credentials or API keys. If you use KDDI's email services, change your password today, even if you have not been notified yet. Monitor your own logs for credential stuffing attacks. The 12 million email addresses from KDDI are now in the hands of attackers. They will use them to try logging into other services. If your users reuse passwords, you will see spikes in failed login attempts. Finally, treat dark web claims as intelligence, not as confirmation. But do not dismiss them either. The cost of investigating is lower than the cost of being caught unprepared.

Women In Optometry
Jun 19th, 2026
Broadening toric options for astigmatic patients.

Broadening toric options for astigmatic patients. June 19, 2026 At the American Optometric Association 2026 in Phoenix, Alcon introduced expansion of its astigmatism contact lens offerings for PRECISION1(R), PRECISION7(R) and TOTAL30(R), delivering broad parameter availability across 1-day, 1-week and 1-month replacement lenses, reinforcing its commitment to helping eyecare professionals (ECPs) fit more astigmatic patients in their desired lenses. Astigmatism remains one of the most common vision conditions, yet many patients remain under-corrected or difficult to fit due to historical parameter limitations.[1-3] Expanded parameter availability can help improve first-fit success, reduce the need for refits and provide ECPs with greater flexibility across a broader range of prescriptions and patient needs, [2,3] Alcon said in its announcement. Uncorrected astigmatism can impact patients' vision-related quality of life, reduce productivity among working-age adults, and create economic burden for patients and their families.[1] With these expanded parameters, including TOTAL30 for Astigmatism, lenses will cover 99% of astigmatic eyes[*], supporting real-world clinical needs.[4-6] TOTAL30 for Astigmatism contact lenses are now the most readily accessible parameters of the leading monthly replacement toric brands, giving ECPs more options for patients.[5-8,**] "In practice, a lack of parameter options can be a barrier to fitting some astigmatic patients in contact lenses," said Torrey J. Carlson, OD,[+] multi-practice owner and founder of Dr. Torrey J. Carlson & Associates. "The expanded toric parameters will be instrumental in making it easier to find the right fit, streamline appointments and ultimately help more patients fit in lenses." The announcement reflects Alcon's broader focus on advancing a comprehensive contact lens portfolio designed to support a wider range of patient needs across daily, weekly and monthly modalities. "The future of eyecare depends on innovations that help practitioners care for more patients across a wider range of vision and ocular surface needs," said Carla Mack, OD, Head of Global and US Professional Education and Development at Alcon. "From expanded toric parameters to emerging approaches in dry eye, continued innovation is creating new opportunities to improve patient care and fitting success." + Paid Alcon Consultant * All eyes with a spectacle cylinder range of -0.75DC to -3.50DC. ** Based on SKU range comparison between TOTAL30(R) for Astigmatism, BIOFINITY Toric^, and ULTRA for Astigmatism^, as of December 2025 ^Trademarks are property of their respective owners References: * Epidemiology and Burden of Astigmatism: A Systematic Literature Review. Optom Vis Sci. 2023 Mar 1;100(3):218-231. doi: 10.1097/OPX.0000000000001998. Epub 2023 Feb 7. PMID: 36749017; PMCID: PMC10045990. * Gustafson B, Whaley S, Giedd B, Montaquila S, Edwards B, Subbaraman LN. Short-Term fit assessment of a novel daily disposable, toric, silicone hydrogel contact lens. Clin Ophthalmol. 2022 Nov 14;16:3721-3730. doi: 10.2147/OPTH.S370151. PMID: 36407500; PMCID: PMC9673940 * Nathan Efron, Philip B. Morgan, Craig A. Woods, Deborah Jones, Lyndon Jones, Jason J. Nichols, International trends in prescribing toric soft contact lenses to correct astigmatism (2000-2023): An update, Contact Lens and Anterior Eye,Volume 47, Issue 5, 2024,102276, ISSN 1367-0484,https://doi.org/10.1016/j.clae.2024.102276 (https://www.sciencedirect.com/science/article/pii/S1367048424001681) * Alcon data on file, 2017. REF-15290 * TOTAL30 family contact lenses Directions for Use - 2025 * Alcon data on file, 2026. REF-29086 * BAUSCH + LOMB ULTRA MONTHLY Contact Lens Parameters. Bausch + Lomb eye care professional website. Published 2023. Accessed February 3, 2026. https://ecp.bauschcontactlenses.com/siteassets/pdf/ultra-contact-lens-parameters.pdf/ * Product Reference Guide. CooperVision eye care professional website. Published 2025. Accessed February 3, 2026. https://coopervision.com/practitioner/its-products/product-reference-guide

DKSH Holdings Ltd.
Jun 15th, 2026
DKSH and Long Chau join forces to bring dry Eye Disease Screening to Vietnamese communities nationwide.

DKSH and Long Chau join forces to bring dry Eye Disease Screening to Vietnamese communities nationwide. DKSH together with Alcon and Topcon Healthcare supports FPT Long Chau Pharmacy's nationwide dry eye awareness initiative by sponsoring advanced diagnostic equipment and bringing clinically proven eye care solutions to communities across all three regions of Vietnam. Ho Chi Minh City, Vietnam, 15 June 2026 - DKSH Healthcare, an integrated end-to-end healthcare commercialization platform, is proud to support the "Dry Eye Disease Screening Program" a community health initiative launched by FPT Long Chau Pharmacy chain in Vietnam. Together with Alcon Vietnam and leveraging Topcon Healthcare's advanced diagnostic technology, the program will be activated across selected Long Chau pharmacy locations nationwide, spanning all three regions of Vietnam. Dry eye disease is a growing public health concern in Vietnam but often remains widely underdiagnosed as many consumers attribute symptoms, such as eye irritation, fatigue, and blurred vision to temporary discomfort. The program addresses this gap by offering complimentary screenings and professional consultations at participating Long Chau locations, supported by Topcon Healthcare's MYAH diagnostic device alongside Alcon's Systane range as a clinically validated dry eye management solution in combination with DKSH's sponsoring. As the exclusive distributor of Topcon Healthcare's ophthalmic portfolio in Vietnam and a distribution partner for Alcon's consumer eye care products, DKSH plays a uniquely integrated role in the program, bridging healthcare innovation with real-world delivery, and enabling the infrastructure that allows community-level initiatives like this to take place at scale. This reflects DKSH's broader approach to healthcare partnerships in Vietnam. Through its integrated commercialization platform, DKSH bring innovative healthcare solutions to reach patients reliably, compliantly, and sustainably, translating scale, local expertise, and execution discipline into tangible patient outcomes and advancing the commitment to Healthcare for All. Ta Minh Cuong, General Manager, Business Unit Healthcare, DKSH Vietnam shared: "This program is a strong example of what becomes possible when distribution expertise, innovative technology, and trusted healthcare brands come together around a shared purpose. By pairing Topcon Healthcare's diagnostic capabilities with Alcon's Systane, DKSH is proud to go beyond logistics, enabling access to high-quality, high-standard technical services and evidence-based eye care for Vietnamese consumers, whether through our distribution network or through on-the-ground initiatives like this one." The program is a tangible expression of DKSH's commitment to Healthcare for All: simplifying complexity, strengthening local healthcare ecosystems, and ensuring that quality solutions reach patients and consumers reliably, across every region of Vietnam. About FPT Long Chau FPT Long Chau Pharmacy is one of Vietnam's leading pharmaceutical retail chains, operating under FPT Digital Retail JSC - a member of FPT Group. With over 2,678 outlets nationwide as of end-2025, Long Chau offers a comprehensive range of prescription and over-the-counter medicines, functional foods, medical devices, cosmeceuticals, and everyday health and consumer products. Backed by a nationwide distribution network and a team of professional pharmacists, Long Chau is committed to delivering quality, reliability, and care to customers across every region of Vietnam. www.nhathuoclongchau.com.vn About DKSH For more than 160 years, DKSH has been delivering growth for companies in Asia Pacific, Europe, and North America across its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, e-commerce, distribution and logistics as well as after-sales services, following its purpose of enriching people's lives. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 35 markets with 26,840 specialists, generating net sales of CHF 11.1 billion in 2025. DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health, over-the-counter products and medical devices. With around 7,580 specialists, the Business Unit generated net sales of CHF 5.8 billion in 2025. www.dksh.com/hec

National Institute for Labor Relations Research
May 18th, 2026
Alcon plans expansion in Right to Work West Virginia.

Alcon plans expansion in Right to Work West Virginia. Alcon is planning to expand soon in Right to Work Lesage, West Virginia. In order to accomplish this, the eye care company is investing a total of $81 million in the project. They will also create 75 new jobs! From Area Development Magazine: "We're super excited we can expand and bring new products. [...] This investment opens the door for future growth and continued expansion of our operations in the region." [...] "For decades, Alcon has shown that a global leader can find great success right here in the Mountain State. [...] This expansion demonstrates that West Virginia isn't just a place to do business, but that it's one of the best places in the world for a global leader to thrive." AREA DEVELOPMENT MAGAZINE

Alcon
Apr 29th, 2026
Alcon and ARVO continue partnership to champion innovation at 2026 live Eye Pitch event.

Alcon and ARVO continue partnership to champion innovation at 2026 live Eye Pitch event. April 29, 2026 Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced its continued collaboration with the Association for Research in Vision and Ophthalmology (ARVO) and support of its live Eye Pitch event, taking place at this year's ARVO Annual Meeting in Denver, Colorado, on Tuesday, May 5, 2026. The pitch contest invites ARVO members to present their innovative research, drug or device proposals to a panel of judges from ARVO and the Alcon Seed Fund, an innovation acceleration platform that identifies and invests in early- and mid-stage disruptive innovations within the ophthalmic field. "Looking at future innovation is critical to meeting the evolving needs of our customers and patients worldwide as we aim to advance the standard of eye care," said Franck Leveiller, SVP, Global Research and Development and Chief Scientific Officer, Alcon. "Eye Pitch underscores our dedication to discovering and championing promising early-stage ophthalmic solutions that have the potential to impact clinical practice. Our collaboration with ARVO brings together a dynamic community of researchers, clinicians and entrepreneurs who are shaping the future of vision science. The creativity and scientific rigor showcased through this program reinforce our optimism about what lies ahead - and our commitment to helping translate bold ideas into transformative care." Eye Pitch, hosted by ARVO and supported by Alcon, is a live competitive program held during the ARVO Annual Meeting that spotlights promising early- to mid-stage innovations in eye and vision research. ARVO members developing new treatments, devices, diagnostics and technologies submitted proposals for review by an expert panel, with finalists invited to deliver a five-minute pitch and participate in a live Q&A session. Finalists receive structured mentorship, and winners are awarded cash prizes. The overall winner is also invited to enter the Alcon Seed Fund diligence process for potential investment of up to $1 million to help advance breakthrough ophthalmic innovations aligned with Alcon's strategic priorities. Interest in the program continues to grow, with an increase of 43% from last year. Selected finalists will present on Tuesday, May 5, 2026, from 6:30 to 8:15 p.m. MT, followed by a networking reception. "Being selected for Eye Pitch last year was a meaningful milestone for our team," said Jonathan Labriola, PhD, Director of Operations at Synakis. "The mentorship helped us sharpen our scientific story and commercial strategy, and winning the competition brought valuable visibility to Synakis and reinforced the potential of our work. Connecting with leaders across vision science at ARVO made the experience especially rewarding." In addition to Eye Pitch, Alcon will also announce VisionX at ARVO 2026, which is a new global open innovation initiative of the Alcon Seed Fund designed to bring cross-disciplinary innovation into the industry. VisionX was created to identify breakthrough ideas emerging outside traditional ophthalmology including fields such as artificial intelligence, photonics, advanced materials, robotics, and computational imaging - and connect them to some of the most important challenges in vision science. By engaging researchers, engineers and entrepreneurs whose work may not currently focus on the eye, VisionX creates a structured pathway for early discovery, evaluation and potential advancement of novel technologies. In addition to Eye Pitch and VisionX, Alcon will also support the Alcon Research Institute (ARI), which will host the annual Steven M. Podos Colloquium on Saturday, May 2, at 5:30 p.m. MT at the Hyatt Regency Denver at the Colorado Convention Center. The event will feature leading experts, including Dr. Lisa Ostrin, SUNY College of Optometry, and Dr. Jay Neitz, University of Washington School of Medicine, who will participate in a session titled "Myopia Progression: Mechanisms & Management." The session will be moderated by Dr. Allen C. Ho, Wills Eye Hospital, Thomas Jefferson University, ARI Chair. Learn more and register on the ARI website, and visit Alcon at Booth #8001 in the ARVO Exhibition Hall. About Alcon. Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, Alcon offer the broadest portfolio of products to enhance sight and improve people's lives. Its Surgical and Vision Care products touch the lives of people in over 140 countries and territories each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Its more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com. Media relations. Steven Smith + 41 589 112 111 (Geneva) + 1 817 551 8057 (Fort Worth) [email protected]